ArticleEMBO molecular medicine2024

Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae.

Anais Vieira Da Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.